MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.

NCT05877651 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

BIOLOGICAL: MASCT-I injection

Sponsor

HRYZ Biotech Co.